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MEASUREMENT OF THE STAPHYLOCOCCAL EPIDERMOL YTIC TOXIN: 
A COMPARISON OF BIOASSAY, RADIAL IMMUNODIFFUSION, 
AND RADIOIMMUNOASSAY 
KIRK D. WUEPPER, M.D., DIANE HAAS BAKER, M.D., AND ROBERT L. DIMO ND , t:A .D. 
Department of Dermatology, School of M edicine, Univ ersity of Oregon Health Sciences Center, 
Portland, Oregon, U.S.A. 
T hree methods of m easurin g t he epidermolytic toxin of Staphy lococcus aureus-bioassay 
in newborn m ice, radia l immunodiffusion , a nd ra dioimmunoassay-were compa red for 
re producibili ty, s pec ificity, and sens it ivity. The bioassay is highly s pecifi c a nd remains the 
only functiona l assay. It is reproducible only if newb orn mice of t he sa me age a re used . The 
t ime req uired fo r epidermolysis fo llows a dose- response relat ionship only if concent rat ions of 
toxin la rge enough to ca use peeling in 90 min or less a re used . This limits the sensit ivi ty of t he 
bioassay to a bout 5 J.L g per m\. 
S ingle radi a l immunodiffus ion in agar is a s pecifi c and reproducible assay method , but its 
sensit ivity is a lso a bout 5 J.L g per m\. 
A radioimmunoassay was established by t he F a rr tec hn ique using puri fied epidermolysin 
radiolabeled wi t h '25iodine. This assay was hi ghly reproducible a nd s pecifi c. The staphylo-
coccal products, a-toxin and enterotox ins A and B , did not cross-react with ant i-epider-
m olysin ant ibodies. The sensitivity of t he radioimmunoassay is 20 n g per m\. 
In 1970 M elish and G lasgow proposed t ha t a n 
epidermolytic toxin was responsible for t he staphy-
lococcal sca lded-skin syndrome [1] . Since t hen t his 
toxin , (called by va rious a u t hors epidermolys in , 
epidermolyti c toxin , exfoliat in , ex folia ting toxin ), 
has been puri fied and pa rt ia lly cha racterized by 
severa l invest igators [2-6 ]. Accurate measurem ent 
of toxin is necessary to furt her ch a racteri ze it a nd 
to delineate its ro le in Staphy lococc us aureus-
associated sca lded -skin syndrome. 
M easurement of epidermolys in has been limi ted 
to a functiona l bioassay in newborn mice. In our 
laboratories, bioassay resul ts were found to be 
q ui te va ri a ble when t he sa me amoun t of toxi n was 
injected into severa l m ice from di ffere n t li tters. 
Because of t hi s observation , t he fo llowing study 
was underta ken to exa mine the fac tors producing 
variab ili ty in b ioassay resul ts . We have a lso d eve l-
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the reciprocal of the serum dilu tion which precipi-
tates 33% of the antigen added 
BSA: bov ine se ru m albumin 
op ed other more sensit ive a nd reproducible ways to 
m easure t he epidermolytic toxin , radia l immuno-
diffusion , and radioimmunoassay. 
MATERIALS AND METHODS 
Epidermolyt ic toxin was obta ined and purified as 
previously described l6 ] from Strain EV, a phage group 
II , type 55/71, coagulase-posit ive S . aureus, isolated from 
a case of sta phylococca l scalded-skin syndrome. Anti-
serum to epidermolysin was produced in rabbits as 
previously descri bed [6 j. 
Bioassay 
Newborn Webster/Swiss mice (Simonson Laborato-
ries, Gi lroy , Calif.) of known age (1 to 5 days) were 
injected subcutaneously, in duplicate, in to the nape of 
the neck. We used 25-gauge needles, and 0.02- ml volumes 
of material were assayed for epidermolytic tox in activity. 
The time required for production of a localized Nikolsky 
sign in the skin overlyi ng the site of injection was 
recorded as the end point. 
Radia l Immunodiffusion 
Rad ial immunodiffusion in agar was carried out ac-
cording to the method of Mancini et al [7] . In brief, a 
1.5% agar gel plate (lonagar No.2, Difco , Detroit, Mich.) 
was prepared with 7.5% rabbit ant iserum to epider-
molys in incorporated into the agar. Circul ar wells were 
cut into the agar to allow introduction of 7-/l1 amounts of 
the material to be assayed fo r epidermolysin . Radi al 
diffusion took place over a 7- to 10-day period at room 
temperature in humidity chambers. The diameters of the 
circular precipi t in bands that formed were measured 
using a mi croscope oc ular eq uipped with a micrometer, 
and the areas of the circles were calculated. Known 
amounts of epiderm olysin were introduced into wells in 
the same agar gel plate in which unknowns were mea-
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s ured , a llowing a standa rd cu rve to be prepared for each 
assay run . 
Radiolabeling of Epidermolysin 
Purifi ed epid ermolysin was radioiodin ated wi t h 
I" iodine (1 mCi/50 Ill , New England Nuclea r, Boston, 
Mass.) and 50 III of chloramine T (1 mg/ ml) were added 
to purified epidermolysin (1200 Ilg in 0.5 mI). Fifty III of 
sodi um metabisulfi te (1 mg/ml) were added to terminate 
the reaction . Bovine se rum a lbumin (BSA) (Schwa rz/ 
Mann, Ora ngeburg, N .Y.), 0 .2% in sa line, was added as 
carr ie r. Free "'I was separated from radiola beled epider-
rnolys in by extensive dia lysis and passage over a Sepha -
d ex G-50 column [8 1. 
Saturated ammonium sulfate precipitation was inves-
t igated as a means of separat ing free from a nt ibody-
bound epidermolysin [9 J. Radiolabeled epidermolys in 
was in cubated overnight at 4°C. with phosphate- buffered 
sa line, ra bbit serum , human serum, or rabbit antiserum 
to epidermolys in . Cold sa t urated ammonium sulfa te was 
then added in amounts sufficient to obtain final concen-
t rations of ammonium sulfate from 20 to 90%. The 
precipitate which formed was centrifuged, separated 
from the supernatant, and counted in a well- type ga mma 
counter. 
Characterization of the Rabbit Antiserum Used in the 
Radioim munoassay 
Rabbit antiserum to epidermolysin was tested for its 
abil ity to bi nd rad iolabeled epidermolysi n as fo llows: 0.5 
m! of doubling di lu tions of anti-epidermolys in was incu-
bated overni ght at 4°C. with constant amounts of 
(I2>IJepidermolysin (100 ng in 0.5 mI) . Following incuba-
tion, 1.0 ml of saturated ammonium sulfate was added. 
Precipita tes were cent rifuged at 4°C at 3000 g for 20 min , 
washed with 50% sat urated ammon ium s ulfate, recen -
t ri fuged , a nd radioactivity in precipitates was coun ted in 
a well- type ga mma counte r. 
Assay System 
T o assay unknown samples for epidermolys in the 
fo llowing syste m was used: 0.5 ml of' rabbit anti-epider-
molysin (1 :750) was added to 0.5 ml of [1251 ]epidermolysin 
and 0.5 ml of varyin g dilut ions of sa mple to be assayed . 
Following incubation overnight at 4°C, 1.5 ml of satu-
rated a mmonium sulfate was added to effect precipitation 
of ant ibody-bound epidermolysin. Precipi tates were cen-
trifuged, was hed with 50% saturated a mm onium sul fate , 
recentrifuged , and radioactivity was determined . A stan-
da rd curve was constructed with known q ua nti t ies of 
epidermolysin, measured by the method of Lowry et al 
(10 I with BSA as standard . 
To determine whether other staphylococca l products-
a -toxin, enterotoxin A, or enterotoxin B-could in-
hibit binding of [1251 Jepidermolysin to rabbit anti-epider-
molys in , [1251 Jepidermolysin (100 ng in 0.5 ml), rabbit 
anti-epidermolys in (1:750, 0 .5 mIl. and a mounts of a 
tox in , ente rotoxin A, or enterotoxin B from 0.5 to 100 Ilg 
were in cubated together overnight at 4°C. Saturated 
ammonium sul fate precipi ta tion , washing, a nd ga mma 
count ing of precipitates were carried out as described . 
RESULTS 
Bioassay of Epidermolysin 
The results of bioassay of a single batch of toxin 
in mice of varying age are given in Figure 1. The 
end point of t he assay, loosening of the epidermis 
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FIG. 1. Dose- response curve to highly purified epider-
molysin injected intracutaneously in mice of varying ages. 
The time required for production of a localized Nikolsky 
sign in skin overlying t he injection site was recorded as 
the end poin t. 
overl yi ng the injection site in response to rubbing 
with a finger (N ikolsky sign) , was clear-cut and 
could be measured accurate ly wi t hin a 2- to 5- min 
in terva l. There was close agreement between du-
plicate an imals. 
The relationship between t he amount of epider-
molysin injected (dose) and the time required for 
epidermolysis to develop (response) was linea r only 
if the response occurred in less t han 60 to 90 min . 
The results became erratic and nonlinear there-
after. As shown in Figure 1, t he dose- response 
varied with t he age of t he mice injected ; t he assay 
was more sensitive in mice less t han 24 hr old . 
To exclude the possibili ty that deterioration of 
the toxin was responsible for t he delayed responses 
observed in older animals, experiments were re-
peated in 1-day-old mice. The resul ts coincided 
with the first determination, confirming that the 
toxin was stable. The minimum time required for 
epidermolysis was about 15 min. This was pre-
sumably due to the t ime required for passive dif-
fusion from the int radermal injection site to the 
overlying epidermis. Apparently, systemic adsorp-
t ion also takes place, since animals which received 
higher doses would develop a positive Nikolsky sign 
at any skin site several hours after the initial injec-
tion . 
Radial Immunodiffusion Assay (Mancini) fo r 
Epidermolysin 
Single radial diffusion of antigen into agar con-
taining a nt ibody to epidermolysin prov ided a re-
producible, convenient assay (Fig. 2). The single, 
sharp rings of precipi tation developed fully in 7 to 
10 days and were suitab le for measurement of toxin 
concentrations from 5 to 75 }.Lg per ml. 
Radioimmunoa.ssay (Farr) for Epidermolysin 
Radiolabelin g of epidermolysin with 1251 did not 
ca use loss of activi ty in the newborn mouse bioas-
say. The minimum detectable concentration of 
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obta ined when known amounts of unlabeled epi -
dermolysi n we re a llowed to compete with [I25I]epi-
d ermolysi n for binding to a nt iserum in t he radio-
immunoassay system (Fig. 5 left panel). Using t he 
logit method for linea rization of data [11], the graph 
in Figure 5 right panel was ob tained. Using t his 
assay we are able to measure epidermolysin in con-
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FIG. 2. Standard curve for measurement of epider-
molys in by single radial immunodiffusion in agar. Inset 
shows typical precipitin rings that develop 7 to 10 days 
after 7-1-'1 sample is in trod uced in to wells cut in agar 
contain ing 7.5% ant ibody. 
[ ' 25I]epidermolysin by bioassay was t he sa me as 
t hat of unlabeled toxin, about 5 Ilg/m l. The labe l 
was indeed bound to t he toxin, s ince radioactivity 
and toxin comigrated in di sc gel electrophores is 
and t he precipitin rin gs which formed in Mancini 
radial diffusion plates conta ined t he radioactivi ty. 
The specific activity of t he [' 25I]epidermolysin was 
0.Q78 Ci/gm. 
The solubility of t he toxin in ammoniu m sulfate 
is shown in Figure 3. With a 50% saturated solu t ion 
of a mmonium sulfate, when [' 25I]epidermolysin 
was incubated with immune rab bit serum (1:100), 
80% of t he rad ioactivity added was precipitated ; 
whereas , when [' 25I]epidermolysin was incubated 
with selected human sera (1:5), norm al rabb it 
serum (1: 5) , or phosphate-buffered sa line, less 
than 5% of t he radioactivity added was prec ipi -
tated. That is, [' 25I ]epidermolysin remains solu-
ble in 50% saturated a mmonium sulfate unless it is 
bound to specific antiserum . This a llows distinct 
separation of free from a ntibody-bound ep ider-
molysin in t he rad ioimmunoassay . 
Figure 4 illustrates the cha racteri zation of the 
ra bbit antiserum selected for use in t he radioim-
munoassay. Antigen-binding capacity, expressed 
as ABC-33, is calculated from t he reciprocal of the 
serum dilu tion which precipitates 33 % of t he 
ant igen added (in this case 2150, as indicated in 
Figure 4). The ABC-33 of t his a nt iserum was 27.7 
Ilg a nti gen nitrogen per ml [9] . In the radioim-
munoassay itself, a dilu t ion of antiserum (1:750) 
capable of precipitating 60% of the ant igen added 
was used . 
A standard curve for com parison when measur-
ing unknown amounts of epidermolysin was 
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FIG. 4. Characterization of the rabbit antiserum used 
in the radioimmunoassay for epidermolysin . The anti-
gen-binding capacity of the antiserum was determined 
from the ABC-33 end point which is indicated on the 
graph. 
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Flc. 5. Standard curve for measurement of epider-
molysin by radioi mmunoassay. The left panel shows raw 
data obtained when known amounts of "cold" epider-
molysin were allowed to compete for binding to anti -
serum with 1m ! lepidermolysin in the assay system. The 
right panel represents the same data plotted by t he logit 
method for linearization of radioimmunoassay data. 
centrations from 20 to 250 ng per m!. Staphylococ-
cal a-toxin, enterotoxin A, or enterotoxin B did not 
significantly inhibit binding of [' 25IJepidermolysin 
to rabbit anti-epidermolysin. 
M easurem ent of [' 25l]Epidermolysin in Viu o 
After injection of 20 Il g of [' 251 Jepidermolys in 
in traperitoneally in 6 I-day-old mice, blood was 
obtained at 30- min interva ls from the tail vein in 
10-111 hepa rini zed microp ipets. The whole blood 
leve ls of epidermolysin up to t he time of general -
ized pee ling or death are shown in Figure 6. Four 
a nima ls survived the experiment a nd ex perienced 
genera li zed pos it ive Nikolsky phenomena . Two 
a nimals di ed, poss ibly due to excess ive blood loss , 
and did not develop epidermolysis. 
Epidermolysin was a lso measured by direct 
gamma radiation coun ting of weighed whole skin 
or peeled epidermis obtained at the t ime of gener-
a li zed pee ling in the four surviving animals as 
shown in Figure 7. The concentration of epider-
molys in in peeled ep idermis see ms to be increased 
compared to the concentrat ion in whole skin or 
blood at t he time of genera li zed peeling. 
DISCUSSIO N 
A systematic eva luat ion of t he fa cto rs t hat 
influence t he measu rement of t he sta phylococca l 
epidermolyt ic toxin by bioassay revea led that the 
age of mice used in t he assay has a critical 
influence on t he results obta ined (Fig . 1). The 
variabi li ty we experienced in day-to-day test ing of 
t he toxin was eliminated if mice of identica l age 
were employed a nd if we used t he linea r porti on of 
the dose- res ponse curve . For t he functiona l assay, 
we recommend t hat a uni t be estab lished which 
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falls within t he linea r portion of the curve. For 
example, we present ly define one unit as that 
quantity of epidermolysin in 0.02 ml which will 
resul t in epidermal separation 60 min after in t ra-
~utaneous injection in a I-day old mouse. In our 
hands, this corresponds to a pproximately 500 ng of 
highly purified epidermolysin. 
We prefer to inject a sma ll volume, 20 Ill , s ince 
appreciable leakage of the injected fluid occurs 
wit h larger volumes (such as 50 or 100 Ill). We a lso 
favor intracutaneous injections and testing for 
Hours ofler Injection 
(!) N,kOl5k1 +. Gentl ollled 
o N.kotsky-, Ol ed 
Flc. 6. Whole veno us blood levels of [125I]epider-
molysin followin g injection of 20 Il g of [1251 ]epidermolysin 
intra peritonea lly in to each of 6 newborn mi ce. Blood 
levels rose up to the time when a generalized posit ive 
Nikolsky sign could be elicited, 3 to 4 hr post injec tion. 
Two animals died before peeling occurred. 
0 -- 0 Nlkolsky - ,Di ed 
• 
.-e Nlkolsky + ,Generollzed 
OL---~ ______ L-~ __ ~ ____ L-__ ~ ____ ~ 
Blood Whole Sk in EpidermIS 
Flc. 7. 1' 2 '1 JEpidermolysin levels in blood, whole 
skin, and peeled epidermis of four newborn mice at the 
time of generalized peeling 3 to 4 hr post intraperi toneal 
injection of 20 /Lg per mouse. The toxin seemed to be 
concentrated in peeled epidermis on a Il g per gm basis 
as compared to whole skin or blood. 
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peeling in the skin overlying the Injection site, 
because the time required for assay is short by this 
method and the assay has a crisp end point. The 
animals need not be returned to their mothers in 
such short-term experiments and this prevents loss 
due to cannibalism. 
The minimum detectible concentration of epi -
dermolysin in the bioassay is 5 J.L g per ml (100 ng in 
0.02 ml), although wi t h this dose peeling is usua lly 
noted 3 to 4 hr after injection and occurs in the 
nonlinear port ion of the dose-response curve. T o 
our knowledge , the only func t ional assay of epider-
molysin is t he bioassay. 
1mmunoassays offer an advantage of precision 
and reproducibility but do not measure fun ction . 
Radial immunodiffusion is readily adapted to 
prec ise measurement of the toxin . The sensitivity 
of this assay was similar to bioassay, since t he 
minimum concent ration that could be measured 
accurately by thi s assay was a lso about 5 J.L g per ml. 
Radia l immunodiffusion is useful for prepara tive 
studies and toxin purification , since it does not 
require t he use of labora tory anima ls. However, for 
measurement of tox in or ant ibody to toxin in 
serum or body fluids in a clinica l setting, a still 
more sensitive assay method , the radioimmunoas-
say, was required. Bioassay or radi a l immunodiffu-
sion did not detect toxin in serum of children 
experiencing the staphylococcal scalded-skin syn-
drome. 
S ince the tox in was soluble in ha lf-saturated 
ammonium sulfate, a single anti body radioim -
munoassay was readily developed using t he Fa rr 
technique [9 ]. Its sensitivity is as low as 20 ng per 
ml and its speci fi city was established by addi t ion 
of known quant it ies of cold epidermolysin to 
serum . The staphylococcal products a-tox in , en-
terotoxin A, or enterotoxin B did not inhibit 
binding of [1251 )epidermolysin to specific antibody 
in the radioimmunoassay, nor did they form precip-
itin bands aga inst rabbit anti-epidermolysin by 
double immunodiffusion in agar (method of Ouch-
te rJony) . 
Kondo and associates have recent ly reported the 
existence of two serotypes of epidermolysin [12, 
13]. Phage group II S . aureus strains usually 
produce t he heat-stable epidermolysin ; non-phage 
group II organisms produce a less stable toxin 
whi ch is ant igenically distinct . Some organisms 
produce both types. The epidermolysin from t he S. 
aureus isolate we studied was heat stable and gave 
a single prec ipitin band in Ouchterlony double 
immunodiffusion studies [6 ]. Therefore, our radio-
immunoassay may not detect the less stable 
epidermolysin . Wiley and associates have reported 
the development of a primary binding assay for 
human ant ibody to epidermolys in [14 ), but gave 
no data on measurement of epidermolysin itse lf. 
We detected radioactivity in the blood , whole 
skin , and peeling epidermis 3 hr a fter in t ra peri to-
nea l injection of [1 25Ijepidermolysin in newborn 
mice. [1 251 ]epidermolysin was concent rated 2- to 
Vol. 67, No. 4 
3-fold in the epidermis as compa red to whole skin 
or blood . Although no conclusions about mecha -
nism of action can be drawn from this study, it 
does suggest tha t epidermolysin binds preferen -
tially to a site or sites in t he epidermis. 
S . aureus-associated sca lded-skin syndrome 
is a dramatic but rarely fa tal form of epidermal 
injury. Toxic epidermal necrolysis of nonstaph-
ylococcal origin, usually caused by drugs. is 
more often fatal and is difficult to distinguish 
clinically from the S . aureus-assoc iated disease. 
The trea t ment of these two diseases differs, so 
early dis tinction between them is important. We 
plan to use the radioimmunoassay to study this 
problem , and to study the other forms of the 
sta phylococca l sca lded -skin syndrome, staphylo-
coccal scarlatiniform erupt ion and bullous impe-
tigo. 
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Morse generously supplied staphylococcal enterotoxins A 
and B and antisera to t hese enterotoxins. 
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